5604 results
Refine Your Search
The Leukemia & Lymphoma Society (LLS) Data at ASH Provides Glimpse into the Future of Blood Cancer Treatment
New data from LLS master clinical trials — Beat AML® and Pediatric Acute Leukemia (PedAL) — show promise for leukemias Leaders available to provide …
News Release
The Leukemia & Lymphoma Society (LLS) Data and Presence at ASH Showcase Latest Blood Cancer Treatment Breakthroughs
Numerous researchers and Therapy Acceleration Program (TAP) partners will present data on the most recent developments in blood cancer.LLS’s scientif…
News Release
FDA Approves New Drug to Treat a Serious Immune Condition that Can Affect Children with Blood Cancer
Ryoncil® is for children months and older who get acute disease () after a stem cell transplant RYE BROOK, N.Y., January , – The U.S. Food and Dru…
Blood Cancer
The Leukemia & Lymphoma Society Denounces Federal Actions that Threaten Cancer Patients
WASHINGTON, February , – As the nation’s largest organization serving the critical needs of blood cancer patients, we are alarmed by recent actions t…
News Release
The Leukemia & Lymphoma Society Announces Reimagined Executive Leadership Team
See full multimedia release here.
News Release
The Leukemia & Lymphoma Society 2025 Research Grants Include Acute Leukemia in Children with Down Syndrome
LLS has more than $ million research funding commitments to propel the next generation of blood cancer care Patient education, financial support and a…
News Release
Latest FDA Approval in Multiple Myeloma May Reduce Treatment Costs, Frequency and Side Effects
The FDA’s approval of a less frequent treatment regimen in patients with multiple myeloma highlights a trend of making treatments easier for blood can…
News Release
Kura Oncology’s Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society’s Pediatric Acute Leukemia (PedAL) Master Clinical Trial
SAN DIEGO, December , – Kura Oncology, Inc. (NASDAQ: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines fo…
News Release
Global Partnership to Fund Groundbreaking Research in Treatment of Multiple Myeloma
Groundbreaking research aimed at translating novel chimeric antigen receptor (CAR) therapies into improved treatment for multiple myeloma is the late…
News Release
First 2025 New Blood Cancer Drug Approval Adds Years of Life for People Living with Mantle Cell Lymphoma
Mantle cell is an aggressive form of lymphoma Rye Brook, N.Y., January , – Acalabrutinib (Calquence®) is the first ever drug of its type approved f…
News Release
FDA’s Recent Approval of 2 CAR T-Cell Therapies a ‘Big Step Toward’ Long-Term Control of Myeloma for More Patients
The FDA has approved (Carvykti™) and (Abecma®) for earlier treatment of multiple myeloma.RYE BROOK, N.Y., April , – The U.S. Food and Drug Administ…
News Release
FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma
RYE BROOK, N.Y., March , – Today’s vote by the FDA’s Oncologic Drugs Advisory Committe (ODAC), a group of independent cancer experts, stating that th…
News Release
FDA Expands Use of Leukemia Treatment to Include Children
LLS supported the very first conjugate gemtuzumab ozogamicin, which targets CD33, and was approved in to treat acute myeloid leukemia.
News Release
FDA Approves Treatment for Myelofibrosis and Anemia
RYE BROOK, N.Y., September , – The U.S. Food and Drug Administration (FDA) recently approved momelotinib (Ojjaara™) for use in adults with intermedia…
News Release
FDA Approves Targeted Therapy for Patients with Newly Diagnosed Multiple Myeloma
LLS was an early funder of research that identified the CD38 protein as a target for blood cancer treatment RYE BROOK, N.Y., October , – The U.S. Fo…
News Release
FDA Approves Targeted Immunotherapy for Aggressive Forms of Follicular Lymphoma
Epcoritamab works by engaging the immune system to kill cancer cells RYE BROOK, N.Y., June , – The U.S. Food and Drug Administration (FDA) on Wednesd…
News Release
FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia
Asciminib provides another option to help CML patients live longer, healthier lives RYE BROOK, N.Y., December , – The U.S. Food and Drug Administrati…
News Release
FDA Approves a New Immune-Based Treatment Option for People with Mantle Cell Lymphoma
The FDA continues to expand availability of breakthrough CAR immunotherapy to benefit more blood cancer patientsRYE BROOK, N.Y., May , – The U.S. Fo…
News Release
Ella
Meet Ella. Lymphoma survivor. cheerleader. Ella's first symptoms, at age /, had all the indications of child abuse, until doctors discovered a large…
FDA Approves New Targeted Treatment for Acute Myeloid Leukemia
RYE BROOK, N.Y., July , – The U.S. Food and Drug Administration (FDA) last week approved quizartinib (Vanflyta®) in combination with standard chemoth…
News Release
The Follicular Lymphoma Foundation Joins Forces With The Leukemia & Lymphoma Society to Bring Hope to Those Living With Follicular Lymphoma
AUGUST , - The Follicular Lymphoma Foundation (FLF) and The Leukemia & Lymphoma Society (LLS) have joined forces in an unprecedented strategic partne…
Research: Grants
The Leukemia & Lymphoma Society and Blood Cancer UK Team Up to Award $4.25M for Research into Ways to Prevent Leukemia
RYE BROOK, N.Y., February , — The Leukemia & Lymphoma Society (LLS) and Blood Cancer UK announced today a , $. million grant to launch a research pro…
News Release
The Leukemia & Lymphoma Society Honors 6 Scientists for their Contributions to Blood Cancer Research at Event During American Society of Hematology Annual Meeting
San Diego, December , – Using the latest genetic tools, Elvin Wagenblast, Ph.D., is dissecting blood cells to explain exactly why and how some go fr…
News Release
Shred For Red: Communities Nationwide to Join Olympians at Deer Valley Resort to Support Blood Cancer Patients
(RYE BROOK, N.Y., November , ) - The Leukemia & Lymphoma Society (LLS) is kicking off the ski season by gathering communities nationwide at LLS’s "Shr…
News Release
Skies Across North America to Light Up This Fall in Support of Blood Cancer Patients
The Leukemia & Lymphoma Society kicks off philanthropic campaign Light The Night; communities nationwide encouraged to learn why awareness and support…
News Release